Reduced Price

VishaySMAJ18CA-E3/61Transient Voltage Suppressors (TVS)

Diode TVS Single Bi-Dir 18V 400W 2-Pin SMA T/R

Sleep easy, never worry about surges again with this SMAJ18CA-E3/61 TVS diode from Vishay. Its peak pulse power dissipation is 400 W. This device's maximum clamping voltage is 29.2 V and minimum breakdown voltage is 20 V. Its test current is 1 mA. Its maximum leakage current is 1 μA. This TVS diode has an operating temperature range of -55 °C to 150 °C. In order to ensure safe delivery and enable quick mounting of this component after delivery, it will be encased in tape and reel packaging during shipment.

Total In Stock: 67,098 parts

Regional Inventory: 4,098

    Total$0.10Price for 1

    4,098 In stock: Ships tomorrow

    • Service Fee  $7.00

      Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2226+
      Manufacturer Lead Time:
      11 weeks
      Minimum Of :
      1
      Maximum Of:
      3599
      Country Of origin:
      Taiwan
         
      • Price: $0.1006
      Spliced leader/trailer tape per EIA standards Leader tape:400mm=15.75'; Trail tape:160mm=6.3' more information
    • Ships tomorrow

      Ships from:
      United States of America
      Date Code:
      2226+
      Manufacturer Lead Time:
      11 weeks
      Country Of origin:
      Taiwan
      • In Stock: 498 parts
      • Price: $0.1006
    • (3600)

      Ships tomorrow

      Increment:
      3600
      Ships from:
      United States of America
      Date Code:
      2509+
      Manufacturer Lead Time:
      11 weeks
      Country Of origin:
      Taiwan
      • In Stock: 3,600 parts
      • Price: $0.06
    • (1800)

      Ships in 2 days

      Ships from:
      Netherlands
      Date Code:
      2536+
      Manufacturer Lead Time:
      11 weeks
      Country Of origin:
      China
      • In Stock: 63,000 parts
      • Price: $0.0608

    Design AI-powered medical devices

    Explore system design tips, part recs and AI insights to help you build faster, safer diagnostic and therapy solutions—all in Arrow’s latest white paper.